Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Diabetes Medicines Market Research Report 2024

Global Diabetes Medicines Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-05-17

Pages: 103 Pages

Report ld: 2467327

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global Diabetes Medicines market was valued at US$ 97410 million in 2023 and is anticipated to reach US$ 207020 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.

Diabetes Medicines Market Size

M= millions and B=billions

Global Diabetes Medicines key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%.
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Medicines.

The Diabetes Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Diabetes Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetes Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Report Metric
Details
Report Title
Global Diabetes Medicines Market Research Report 2024
Forecasted Market Size in 2030
US$ 207020 million
CAGR(2024-2030)
11.2%
Market Size Available for Years
2019-2030
Global Diabetes Medicines Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Medicines Market, Segment by Type
Oral

Injection
Global Diabetes Medicines Market, Segment by Application
Hospital

Retail Pharmacy
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetes Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetes Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 Diabetes Medicines Market Overview
    1.1 Product Definition
    1.2 Diabetes Medicines by Type
        1.2.1 Global Diabetes Medicines Market Value Comparison by Type (2024-2030)
        1.2.2 Oral
        1.2.3 Injection
    1.3 Diabetes Medicines by Application
        1.3.1 Global Diabetes Medicines Market Value by Application (2024-2030)
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Global Diabetes Medicines Market Size Estimates and Forecasts
        1.4.1 Global Diabetes Medicines Revenue 2019-2030
        1.4.2 Global Diabetes Medicines Sales 2019-2030
        1.4.3 Global Diabetes Medicines Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Diabetes Medicines Market Competition by Manufacturers
    2.1 Global Diabetes Medicines Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Diabetes Medicines Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Diabetes Medicines Average Price by Manufacturers (2019-2024)
    2.4 Global Key Players of Diabetes Medicines, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Diabetes Medicines, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Diabetes Medicines, Product Type & Application
    2.7 Global Key Manufacturers of Diabetes Medicines, Date of Enter into This Industry
    2.8 Global Diabetes Medicines Market Competitive Situation and Trends
        2.8.1 Global Diabetes Medicines Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Diabetes Medicines Players Market Share by Revenue
        2.8.3 Global Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Global Diabetes Medicines Market Scenario by Region
    3.1 Global Diabetes Medicines Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Diabetes Medicines Sales by Region: 2019-2030
        3.2.1 Global Diabetes Medicines Sales by Region: 2019-2024
        3.2.2 Global Diabetes Medicines Sales by Region: 2025-2030
    3.3 Global Diabetes Medicines Revenue by Region: 2019-2030
        3.3.1 Global Diabetes Medicines Revenue by Region: 2019-2024
        3.3.2 Global Diabetes Medicines Revenue by Region: 2025-2030
    3.4 North America Diabetes Medicines Market Facts & Figures by Country
        3.4.1 North America Diabetes Medicines Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Diabetes Medicines Sales by Country (2019-2030)
        3.4.3 North America Diabetes Medicines Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Diabetes Medicines Market Facts & Figures by Country
        3.5.1 Europe Diabetes Medicines Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Diabetes Medicines Sales by Country (2019-2030)
        3.5.3 Europe Diabetes Medicines Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Diabetes Medicines Market Facts & Figures by Region
        3.6.1 Asia Pacific Diabetes Medicines Market Size by Region: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Diabetes Medicines Sales by Region (2019-2030)
        3.6.3 Asia Pacific Diabetes Medicines Revenue by Region (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Diabetes Medicines Market Facts & Figures by Country
        3.7.1 Latin America Diabetes Medicines Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Diabetes Medicines Sales by Country (2019-2030)
        3.7.3 Latin America Diabetes Medicines Revenue by Country
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
        3.7.7 Colombia
    3.8 Middle East and Africa Diabetes Medicines Market Facts & Figures by Country
        3.8.1 Middle East and Africa Diabetes Medicines Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Diabetes Medicines Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Diabetes Medicines Revenue by Country
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Diabetes Medicines Sales by Type (2019-2030)
        4.1.1 Global Diabetes Medicines Sales by Type (2019-2024)
        4.1.2 Global Diabetes Medicines Sales by Type (2025-2030)
        4.1.3 Global Diabetes Medicines Sales Market Share by Type (2019-2030)
    4.2 Global Diabetes Medicines Revenue by Type (2019-2030)
        4.2.1 Global Diabetes Medicines Revenue by Type (2019-2024)
        4.2.2 Global Diabetes Medicines Revenue by Type (2025-2030)
        4.2.3 Global Diabetes Medicines Revenue Market Share by Type (2019-2030)
    4.3 Global Diabetes Medicines Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Diabetes Medicines Sales by Application (2019-2030)
        5.1.1 Global Diabetes Medicines Sales by Application (2019-2024)
        5.1.2 Global Diabetes Medicines Sales by Application (2025-2030)
        5.1.3 Global Diabetes Medicines Sales Market Share by Application (2019-2030)
    5.2 Global Diabetes Medicines Revenue by Application (2019-2030)
        5.2.1 Global Diabetes Medicines Revenue by Application (2019-2024)
        5.2.2 Global Diabetes Medicines Revenue by Application (2025-2030)
        5.2.3 Global Diabetes Medicines Revenue Market Share by Application (2019-2030)
    5.3 Global Diabetes Medicines Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Novo Nordisk
        6.1.1 Novo Nordisk Company Information
        6.1.2 Novo Nordisk Description and Business Overview
        6.1.3 Novo Nordisk Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Novo Nordisk Diabetes Medicines Product Portfolio
        6.1.5 Novo Nordisk Recent Developments/Updates
    6.2 Sanofi
        6.2.1 Sanofi Company Information
        6.2.2 Sanofi Description and Business Overview
        6.2.3 Sanofi Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Sanofi Diabetes Medicines Product Portfolio
        6.2.5 Sanofi Recent Developments/Updates
    6.3 Eli Lilly
        6.3.1 Eli Lilly Company Information
        6.3.2 Eli Lilly Description and Business Overview
        6.3.3 Eli Lilly Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Eli Lilly Diabetes Medicines Product Portfolio
        6.3.5 Eli Lilly Recent Developments/Updates
    6.4 Merck
        6.4.1 Merck Company Information
        6.4.2 Merck Description and Business Overview
        6.4.3 Merck Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Merck Diabetes Medicines Product Portfolio
        6.4.5 Merck Recent Developments/Updates
    6.5 AstraZeneca
        6.5.1 AstraZeneca Company Information
        6.5.2 AstraZeneca Description and Business Overview
        6.5.3 AstraZeneca Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 AstraZeneca Diabetes Medicines Product Portfolio
        6.5.5 AstraZeneca Recent Developments/Updates
    6.6 bayer
        6.6.1 bayer Company Information
        6.6.2 bayer Description and Business Overview
        6.6.3 bayer Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 bayer Diabetes Medicines Product Portfolio
        6.6.5 bayer Recent Developments/Updates
    6.7 Boehringer Ingelheim
        6.7.1 Boehringer Ingelheim Company Information
        6.7.2 Boehringer Ingelheim Description and Business Overview
        6.7.3 Boehringer Ingelheim Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.7.4 Boehringer Ingelheim Diabetes Medicines Product Portfolio
        6.7.5 Boehringer Ingelheim Recent Developments/Updates
    6.8 Johnson & Johnson
        6.8.1 Johnson & Johnson Company Information
        6.8.2 Johnson & Johnson Description and Business Overview
        6.8.3 Johnson & Johnson Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Johnson & Johnson Diabetes Medicines Product Portfolio
        6.8.5 Johnson & Johnson Recent Developments/Updates
    6.9 Takeda
        6.9.1 Takeda Company Information
        6.9.2 Takeda Description and Business Overview
        6.9.3 Takeda Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 Takeda Diabetes Medicines Product Portfolio
        6.9.5 Takeda Recent Developments/Updates
    6.10 Tonghua Dongbao
        6.10.1 Tonghua Dongbao Company Information
        6.10.2 Tonghua Dongbao Description and Business Overview
        6.10.3 Tonghua Dongbao Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 Tonghua Dongbao Diabetes Medicines Product Portfolio
        6.10.5 Tonghua Dongbao Recent Developments/Updates
    6.11 United Pharmaceuticals
        6.11.1 United Pharmaceuticals Company Information
        6.11.2 United Pharmaceuticals Description and Business Overview
        6.11.3 United Pharmaceuticals Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.11.4 United Pharmaceuticals Diabetes Medicines Product Portfolio
        6.11.5 United Pharmaceuticals Recent Developments/Updates
    6.12 Ganli Pharmaceutical
        6.12.1 Ganli Pharmaceutical Company Information
        6.12.2 Ganli Pharmaceutical Description and Business Overview
        6.12.3 Ganli Pharmaceutical Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.12.4 Ganli Pharmaceutical Diabetes Medicines Product Portfolio
        6.12.5 Ganli Pharmaceutical Recent Developments/Updates
    6.13 Biocon
        6.13.1 Biocon Company Information
        6.13.2 Biocon Description and Business Overview
        6.13.3 Biocon Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.13.4 Biocon Diabetes Medicines Product Portfolio
        6.13.5 Biocon Recent Developments/Updates
    6.14 Conker Pharmaceuticals
        6.14.1 Conker Pharmaceuticals Company Information
        6.14.2 Conker Pharmaceuticals Description and Business Overview
        6.14.3 Conker Pharmaceuticals Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.14.4 Conker Pharmaceuticals Diabetes Medicines Product Portfolio
        6.14.5 Conker Pharmaceuticals Recent Developments/Updates
    6.15 Jiangsu Wanbang
        6.15.1 Jiangsu Wanbang Company Information
        6.15.2 Jiangsu Wanbang Description and Business Overview
        6.15.3 Jiangsu Wanbang Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.15.4 Jiangsu Wanbang Diabetes Medicines Product Portfolio
        6.15.5 Jiangsu Wanbang Recent Developments/Updates
    6.16 Geropharm
        6.16.1 Geropharm Company Information
        6.16.2 Geropharm Description and Business Overview
        6.16.3 Geropharm Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.16.4 Geropharm Diabetes Medicines Product Portfolio
        6.16.5 Geropharm Recent Developments/Updates
    6.17 Wockhardt
        6.17.1 Wockhardt Company Information
        6.17.2 Wockhardt Description and Business Overview
        6.17.3 Wockhardt Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.17.4 Wockhardt Diabetes Medicines Product Portfolio
        6.17.5 Wockhardt Recent Developments/Updates
    6.18 Merck Serono
        6.18.1 Merck Serono Company Information
        6.18.2 Merck Serono Description and Business Overview
        6.18.3 Merck Serono Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.18.4 Merck Serono Diabetes Medicines Product Portfolio
        6.18.5 Merck Serono Recent Developments/Updates
    6.19 Novartis
        6.19.1 Novartis Company Information
        6.19.2 Novartis Description and Business Overview
        6.19.3 Novartis Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        6.19.4 Novartis Diabetes Medicines Product Portfolio
        6.19.5 Novartis Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Diabetes Medicines Industry Chain Analysis
    7.2 Diabetes Medicines Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Diabetes Medicines Production Mode & Process
    7.4 Diabetes Medicines Sales and Marketing
        7.4.1 Diabetes Medicines Sales Channels
        7.4.2 Diabetes Medicines Distributors
    7.5 Diabetes Medicines Customers

 8 Diabetes Medicines Market Dynamics
    8.1 Diabetes Medicines Industry Trends
    8.2 Diabetes Medicines Market Drivers
    8.3 Diabetes Medicines Market Challenges
    8.4 Diabetes Medicines Market Restraints

 9 Research Findings and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Diabetes Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Diabetes Medicines Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Diabetes Medicines Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Diabetes Medicines Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Diabetes Medicines Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Diabetes Medicines Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Diabetes Medicines Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Diabetes Medicines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Diabetes Medicines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Diabetes Medicines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Diabetes Medicines, Product Type & Application
 Table 12. Global Key Manufacturers of Diabetes Medicines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Diabetes Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Medicines as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Diabetes Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Diabetes Medicines Sales by Region (2019-2024) & (K Units)
 Table 18. Global Diabetes Medicines Sales Market Share by Region (2019-2024)
 Table 19. Global Diabetes Medicines Sales by Region (2025-2030) & (K Units)
 Table 20. Global Diabetes Medicines Sales Market Share by Region (2025-2030)
 Table 21. Global Diabetes Medicines Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Diabetes Medicines Revenue Market Share by Region (2019-2024)
 Table 23. Global Diabetes Medicines Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Diabetes Medicines Revenue Market Share by Region (2025-2030)
 Table 25. North America Diabetes Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Diabetes Medicines Sales by Country (2019-2024) & (K Units)
 Table 27. North America Diabetes Medicines Sales by Country (2025-2030) & (K Units)
 Table 28. North America Diabetes Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Diabetes Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Diabetes Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Diabetes Medicines Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Diabetes Medicines Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Diabetes Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Diabetes Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Diabetes Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Diabetes Medicines Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Diabetes Medicines Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Diabetes Medicines Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Diabetes Medicines Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Diabetes Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Diabetes Medicines Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Diabetes Medicines Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Diabetes Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Diabetes Medicines Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Diabetes Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Diabetes Medicines Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Diabetes Medicines Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Diabetes Medicines Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Diabetes Medicines Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Diabetes Medicines Sales (K Units) by Type (2019-2024)
 Table 51. Global Diabetes Medicines Sales (K Units) by Type (2025-2030)
 Table 52. Global Diabetes Medicines Sales Market Share by Type (2019-2024)
 Table 53. Global Diabetes Medicines Sales Market Share by Type (2025-2030)
 Table 54. Global Diabetes Medicines Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Diabetes Medicines Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Diabetes Medicines Revenue Market Share by Type (2019-2024)
 Table 57. Global Diabetes Medicines Revenue Market Share by Type (2025-2030)
 Table 58. Global Diabetes Medicines Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Diabetes Medicines Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Diabetes Medicines Sales (K Units) by Application (2019-2024)
 Table 61. Global Diabetes Medicines Sales (K Units) by Application (2025-2030)
 Table 62. Global Diabetes Medicines Sales Market Share by Application (2019-2024)
 Table 63. Global Diabetes Medicines Sales Market Share by Application (2025-2030)
 Table 64. Global Diabetes Medicines Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Diabetes Medicines Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Diabetes Medicines Revenue Market Share by Application (2019-2024)
 Table 67. Global Diabetes Medicines Revenue Market Share by Application (2025-2030)
 Table 68. Global Diabetes Medicines Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Diabetes Medicines Price (US$/Unit) by Application (2025-2030)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Novo Nordisk Diabetes Medicines Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sanofi Diabetes Medicines Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Eli Lilly Diabetes Medicines Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Merck Diabetes Medicines Product
 Table 89. Merck Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. AstraZeneca Diabetes Medicines Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. bayer Company Information
 Table 96. bayer Description and Business Overview
 Table 97. bayer Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. bayer Diabetes Medicines Product
 Table 99. bayer Recent Developments/Updates
 Table 100. Boehringer Ingelheim Company Information
 Table 101. Boehringer Ingelheim Description and Business Overview
 Table 102. Boehringer Ingelheim Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Boehringer Ingelheim Diabetes Medicines Product
 Table 104. Boehringer Ingelheim Recent Developments/Updates
 Table 105. Johnson & Johnson Company Information
 Table 106. Johnson & Johnson Description and Business Overview
 Table 107. Johnson & Johnson Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Johnson & Johnson Diabetes Medicines Product
 Table 109. Johnson & Johnson Recent Developments/Updates
 Table 110. Takeda Company Information
 Table 111. Takeda Description and Business Overview
 Table 112. Takeda Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Takeda Diabetes Medicines Product
 Table 114. Takeda Recent Developments/Updates
 Table 115. Tonghua Dongbao Company Information
 Table 116. Tonghua Dongbao Description and Business Overview
 Table 117. Tonghua Dongbao Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Tonghua Dongbao Diabetes Medicines Product
 Table 119. Tonghua Dongbao Recent Developments/Updates
 Table 120. United Pharmaceuticals Company Information
 Table 121. United Pharmaceuticals Description and Business Overview
 Table 122. United Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. United Pharmaceuticals Diabetes Medicines Product
 Table 124. United Pharmaceuticals Recent Developments/Updates
 Table 125. Ganli Pharmaceutical Company Information
 Table 126. Ganli Pharmaceutical Description and Business Overview
 Table 127. Ganli Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Ganli Pharmaceutical Diabetes Medicines Product
 Table 129. Ganli Pharmaceutical Recent Developments/Updates
 Table 130. Biocon Company Information
 Table 131. Biocon Description and Business Overview
 Table 132. Biocon Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Biocon Diabetes Medicines Product
 Table 134. Biocon Recent Developments/Updates
 Table 135. Conker Pharmaceuticals Company Information
 Table 136. Conker Pharmaceuticals Description and Business Overview
 Table 137. Conker Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Conker Pharmaceuticals Diabetes Medicines Product
 Table 139. Conker Pharmaceuticals Recent Developments/Updates
 Table 140. Jiangsu Wanbang Company Information
 Table 141. Jiangsu Wanbang Description and Business Overview
 Table 142. Jiangsu Wanbang Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Jiangsu Wanbang Diabetes Medicines Product
 Table 144. Jiangsu Wanbang Recent Developments/Updates
 Table 145. Geropharm Company Information
 Table 146. Geropharm Description and Business Overview
 Table 147. Geropharm Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Geropharm Diabetes Medicines Product
 Table 149. Geropharm Recent Developments/Updates
 Table 150. Wockhardt Company Information
 Table 151. Wockhardt Description and Business Overview
 Table 152. Wockhardt Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Wockhardt Diabetes Medicines Product
 Table 154. Wockhardt Recent Developments/Updates
 Table 155. Merck Serono Company Information
 Table 156. Merck Serono Description and Business Overview
 Table 157. Merck Serono Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Merck Serono Diabetes Medicines Product
 Table 159. Merck Serono Recent Developments/Updates
 Table 160. Novartis Company Information
 Table 161. Novartis Description and Business Overview
 Table 162. Novartis Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Novartis Diabetes Medicines Product
 Table 164. Novartis Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Diabetes Medicines Distributors List
 Table 168. Diabetes Medicines Customers List
 Table 169. Diabetes Medicines Market Trends
 Table 170. Diabetes Medicines Market Drivers
 Table 171. Diabetes Medicines Market Challenges
 Table 172. Diabetes Medicines Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Diabetes Medicines
 Figure 2. Global Diabetes Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Diabetes Medicines Market Share by Type: 2023 & 2030
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Diabetes Medicines Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Diabetes Medicines Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Retail Pharmacy
 Figure 10. Global Diabetes Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Diabetes Medicines Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Diabetes Medicines Sales (2019-2030) & (K Units)
 Figure 13. Global Diabetes Medicines Average Price (US$/Unit) & (2019-2030)
 Figure 14. Diabetes Medicines Report Years Considered
 Figure 15. Diabetes Medicines Sales Share by Manufacturers in 2023
 Figure 16. Global Diabetes Medicines Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Diabetes Medicines Players: Market Share by Revenue in Diabetes Medicines in 2023
 Figure 18. Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Diabetes Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Diabetes Medicines Sales Market Share by Country (2019-2030)
 Figure 21. North America Diabetes Medicines Revenue Market Share by Country (2019-2030)
 Figure 22. United States Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Diabetes Medicines Sales Market Share by Country (2019-2030)
 Figure 25. Europe Diabetes Medicines Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Diabetes Medicines Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Diabetes Medicines Revenue Market Share by Region (2019-2030)
 Figure 33. China Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Diabetes Medicines Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Diabetes Medicines Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Diabetes Medicines Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Diabetes Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Diabetes Medicines by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Diabetes Medicines by Type (2019-2030)
 Figure 52. Global Diabetes Medicines Price (US$/Unit) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Diabetes Medicines by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Diabetes Medicines by Application (2019-2030)
 Figure 55. Global Diabetes Medicines Price (US$/Unit) by Application (2019-2030)
 Figure 56. Diabetes Medicines Value Chain
 Figure 57. Diabetes Medicines Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global Diabetes Medicines market was valued at US$ 97410 million in 2023 and is anticipated to reach US$ 207020 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.